Trial Profile
A Double Blind, Placebo Controlled, Randomised Trial to Investigate the Efficacy of Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 May 2014
Price :
$35
*
At a glance
- Drugs Avotermin (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Renovo
- 20 May 2014 New trial record